Parsaclisib in Combination With CHOP in Participants With Previously Untreated PTCL

NCT05238064 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

PI3Kδ Inhibitor
Parsaclisib
CHOP
PTCL

Interventions

DRUG: Parsaclisib
DRUG: CHOP

Sponsor

Fudan University